Versant Vantage I, L.P.

CIK 1765253 · last filed 2025-09-18

Versant Vantage I, L.P. is a corporate insider who has filed 12 SEC Form 4 insider transactions across 7 companies since 2020. The most recent filing shows the insider sold $15.0M of LVTX on Sep 18, 2025. Across all open-market trades the lifetime net is −$113.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $176.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$176.02M

Companies

7

Total Filings

12

Lifetime Open-Market Net

-$113.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAVA Therapeutics NV (LVTX) Delisted 10%+ Owner 3,358,920 $1.74 $5.84M -$15.01M 1 2025-09-18
GLUE 10%+ Owner 8,355,156 $18.23 $152.36M -$20.43M 1 2024-09-13
BDTX 10%+ Owner 4,107,283 $1.75 $7.19M -$10.78M 5 2024-08-30
Oyster Point Pharma, Inc. (OYST) Delisted 10%+ Owner 2,243,406 $11.17 $25.06M -$73.45M 1 2021-10-20
Repare Therapeutics Inc. (RPTX) Delisted 10%+ Owner 2,825,662 $2.65 $7.49M $0 2 2021-08-09
ALGS 10%+ Owner 3,092,339 $5.28 $16.33M $6.00M 1 2020-10-20
APRE 10%+ Owner 216,669 $0.69 $148.7K $0 1 2020-05-20

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-09-18 LAVA Therapeutics NV (LVTX) Delisted Sell (S) −10,106,604 -$15.01M EDGAR
2024-09-13 GLUE Sell (S) −3,403,278 -$20.43M EDGAR
2024-08-30 BDTX Sell (S) −886,400 -$5.60M EDGAR
2021-10-20 Oyster Point Pharma, Inc. (OYST) Delisted Sell (S) −4,950,000 -$73.45M EDGAR
2021-08-09 Repare Therapeutics Inc. (RPTX) Delisted Other (J) −456,213 $0 EDGAR
2021-02-18 Repare Therapeutics Inc. (RPTX) Delisted Other (J) −1,050,000 $0 EDGAR
2020-12-01 BDTX Mixed −1,742,272 -$1.38M EDGAR
2020-11-06 BDTX Sell (S) −45,392 -$1.50M EDGAR
2020-10-20 ALGS Mixed +6,584,678 $6.00M EDGAR
2020-10-15 BDTX Sell (S) −68,960 -$2.30M EDGAR
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.